Epimune Diagnostics

📍 Berlin, Germany🗓 Founded 2017👥 8 employees💰 Last funded Sep 2020
Medical Equipment Manufacturing🌐 epimune-dx.com
Website LinkedIn
Epimune’s goal is to revolutionize diagnosis and monitoring of patients with disorders of the immune system. Using epigenetics, Epimune develops & commercializes molecular diagnostic tests for immune cell quantification from a drop of blood in multiple immune-related disorders.
2
Total investors
0
Early stage
2
Mid stage
0
Late stage
2017
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Germany
2
Frequently asked questions
Who invested in Epimune Diagnostics?
Epimune Diagnostics has 2 investors on record on gritt.io, 2 mid-stage.
When did Epimune Diagnostics last raise funding?
The most recent investment in Epimune Diagnostics recorded on gritt.io was in September 2020.
When was Epimune Diagnostics founded?
Epimune Diagnostics was founded in 2017.
What industry is Epimune Diagnostics in?
Epimune Diagnostics operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is Epimune Diagnostics based?
Epimune Diagnostics is headquartered in Berlin, Germany.